Intravenous (IF) Aflibercept versus placebo in combination with irinotecan/5-FU (FOLFIRI) for second-line treatment of metastatic colorectal cancer (MCC): Results of a multinational phase III trial (EFC10262-VELOUR)
作者： Eric Van Cutsem , Josep Tabernero , Radek Lakomý , None
DOI:
关键词:
摘要:
参考文章(0)